Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Teva Pharmaceutical Industries ADR (NY: TEVA )

8.760 +0.030 (+0.34%)
Official Closing Price Updated: 7:00 PM EDT, Mar 28, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 7,794,759
Open 8.690
Bid (Size) 8.700 (1)
Ask (Size) 8.920 (255)
Prev. Close 8.730
Today's Range 8.690 - 8.850
52wk Range 6.779 - 11.45
Shares Outstanding 1,110,352,397
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Is Big Pharma Coming For Your Cannabis Business?
Cannabis stocks have struggled in the market in recent years as the industry push to gain ground on the regulatory front hasn't progressed as quickly as investors had hoped. Yet beverage companies... 
Via Benzinga
Teva’s Digital Health Collaboration with Rimidi Expands to Include Respiratory Monitoring Program Integration with a Large U.S. Health System
From Teva Pharmaceutical Industries Limited
Via Business Wire

Performance

YTD
-8.08%
-8.08%
1 Month
-11.52%
-11.52%
3 Month
-4.89%
-4.89%
6 Month
+13.18%
+13.18%
1 Year
+2.34%
+2.34%

More News

Read More
7 Strong Buy Stocks Under $10 to Snap Up Now
Via InvestorPlace
3 No-Brainer Stocks to Buy With $10 Right Now
Via The Motley Fool
Catalyst Pharma The No. 1 Biotech, Just Crushed 2023 Guidance Estimates
Via Investor's Business Daily
Teva Announces Early Tender Results of its Debt Tender Offer, Increases to Tender Caps and Election of Early Settlement
From Teva Pharmaceutical Industries Limited
Via Business Wire
7 Core Stocks to Build a Solid Portfolio Around
Via InvestorPlace
Teva and Natco Announce Launch of additional strengths for the Generic Version of Revlimid® (lenalidomide capsules), in the U.S.
From Teva Pharmaceutical Industries Limited
Via Business Wire
BRTX’s ThermoStem®: A New Weapon In The Fight Against Metabolic Syndrome
Via TheNewswire.com
BRTX’s ThermoStem®: A New Weapon In The Fight Against Metabolic Syndrome
Via News Direct
BRTX's ThermoStem®: A New Weapon In The Fight Against Metabolic Syndrome
Via Benzinga
Teva to Present at the Barclays Global Healthcare Conference
From Teva Pharmaceutical Industries Limited
Via Business Wire
Better Generics Pharmaceutical Stock: Teva or Viatris?
Via The Motley Fool
Teva Announces Successful Upsize and Pricing of $2,490,000,000 (equivalent) Sustainability-Linked Senior Notes and the Increase of the Maximum Tender Amount of its Debt Tender Offer
From Teva Pharmaceutical Industries Limited
Via Business Wire
7 Smart Stock Picks for Cautious Investors
Via InvestorPlace
Teva Announces $2,250,000,000 Debt Tender Offers for Notes Due 2023-2026
From Teva Pharmaceutical Industries Limited
Via Business Wire
Teva Announces Launch of $2,060,000,000 (Equivalent) Offering of Sustainability-Linked Senior Notes
From Teva Pharmaceutical Industries Limited
Via Business Wire
Teva to Present New Data from CONNECT2 Study on its Digihaler® System at the American Academy of Allergy, Asthma and Immunology (AAAAI) 2023 Annual Meeting
From Teva Pharmaceutical Industries Limited
Via Business Wire
Teva Announces Publication of New Clinician Scale in Journal of Clinical Psychiatry to Assess the Impact of Tardive Dyskinesia on Patients’ Lives
From Teva Pharmaceutical Industries Limited
Via Business Wire
Walmart, Home Depot And 3 Stocks To Watch Heading Into Tuesday
Via Benzinga
Teva Announces FDA Approval of AUSTEDO® XR (deutetrabenazine) Extended-Release Tablets, a New Once-Daily Formulation of AUSTEDO® (deutetrabenazine) Tablets
From Teva Pharmaceutical Industries Limited
Via Business Wire
A Patent Cliff Is Coming For Bristol — Can Billions In New Products Fill The Gap?
Via Investor's Business Daily
Axsome Therapeutics (AXSM) Stock Falls as Teva Pursues Generic Depression Drug
Via InvestorPlace
Teva Plots Its Knockoff Of Axsome's New Depression Drug, Sending The Biotech Sprawling
Via Investor's Business Daily
Teva Reaches Agreement With Florida to Settle the State’s Price Fixing Claims
From Teva Pharmaceutical Industries Limited
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.